Gut Microbiota as a Biomarker and Target in Biologic Therapy for Autoimmune and Immune-Mediated Arthritis- a Systematic Review
Biologic therapy modulates gut microbiota composition in autoimmune and immune-mediated arthritis, promoting a shift toward eubiosis. Specific microbial taxa, including <i>Lachnospiraceae</i>, <i>Blautia</i>, and <i>Faecalibacterium prausnitzii</i>, show potential as noninvasive biomarkers for treatment response and disease activity. These findings guide further longitudinal and interventional studies to validate microbial signatures and their clinical applicability.
Authors
- Mohamed Sayed Zaazouee (ORCID: https://orcid.org/0000-0003-0904-9153)
- Rewanth Katamreddy
- R. Madhumitha (ORCID: https://orcid.org/0000-0002-0042-4992)
- Karthik Mathialagan
- Arya Akhila Perumangote vasudevan
Institutions
- Texas Tech University (US)
- Cleveland Clinic (US)
- University of Connecticut (US)
- The University of Texas at El Paso (US)
- Al-Azhar University (EG)
- SUNY Upstate Medical University (US)
- Guthrie Robert Packer Hospital (US)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2026-02-15
- DOI
- https://doi.org/10.3899/jrheum.2025-0915
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00